Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II/III Trial Investigating if Concomitant Injections of the Diagnostic Agents C-Tb and 2 T.U Tuberculin PPD RT 23 SSI Affect the Induration Responses in Combination With a Safety Assessment of C-Tb

NCT01779102 is registered in ClinicalTrials.gov with Statens Serum Institut as lead sponsor.

NCT NCT01779102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01779102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II/III Trial Investigating if Concomitant Injections of the Diagnostic Agents C-Tb and 2 T.U Tuberculin PPD RT 23 SSI Affect the Induration Responses in Combination With a Safety Assessment of C-Tb
Lead sponsor
Statens Serum Institut
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2013
Completion date
September 30, 2014
Enrollment
456 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis